Blackthorn Therapeutics' Grant

Blackthorn Therapeutics raised a round of funding on June 20, 2017. Investors include National Institutes of Health.

Blackthorn Therapeutics is developing targeted medicines for neurodevelopmental disorders. BlackThorn leverages its INFORM platform, which supports the discovery and development of targeted treatments…

Articles about Blackthorn Therapeutics' Grant: